Medicare Enrolled
Dr. Suhail Sharif, MD
Surgical Oncology Physician · Fort Worth, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sharif from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sharif?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sharif
Dr. Suhail Sharif is a surgical oncology physician in Fort Worth, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sharif performed 654 Medicare services across 519 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sharif received a total of $126,795 from 61 pharmaceutical and/or device companies across 604 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgical oncology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sharif is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in TX
$126,795 industry payments
Medicare Practice Summary
Medicare Utilization ↗654
Medicare services
Top 5% in TX for surgical oncology physician
519
Unique beneficiaries
$127
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~34 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
153 | $62 | $207 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
83 | $126 | $425 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
77 | $88 | $255 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
64 | $100 | $385 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $68 | $170 |
| Biologic implant to soft tissue A procedure involving the placement of a biologic implant into soft tissue. |
34 | $165 | $1,134 |
| Abdominal endoscopy A diagnostic procedure using an endoscope to examine the abdomen. |
33 | $157 | $2,178 |
| Therapy procedure using a special bandage and vacuum pump, surface area more than 50.0 sq cm | 24 | $21 | $211 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
22 | $65 | $317 |
| Central venous port insertion A surgical procedure to place a small reservoir under the skin for long-term access to the bloodstream. The device is connected to a vein to allow for repeated medication administration or blood draws. |
21 | $220 | $3,736 |
| Fluoroscopic guidance for central vein access device Use of live X-ray imaging to guide the placement or removal of a central vein access device. |
21 | $14 | $409 |
| Limited abdominal ultrasound A focused ultrasound examination of the abdomen to evaluate specific organs or areas. This procedure uses sound waves to create images of internal structures. |
20 | $22 | $121 |
| Removal of abdominal lymph nodes Surgical removal of lymph nodes located in the abdomen. This procedure involves excising lymphatic tissue from the abdominal region. |
14 | $202 | $1,987 |
| Endoscopic hernia repair with mesh A minimally invasive procedure to repair a hernia at the junction of the esophagus and stomach using an endoscope and mesh implantation. |
14 | $1,322 | $8,559 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $69 | $278 |
| Partial removal of liver tissue A surgical procedure to remove a portion of the liver. This may be performed to treat disease or remove damaged tissue. |
13 | $479 | $3,229 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$126,795
Total received (2018-2024)
Avg $18,114/year across 7 years
Top 2% in TX for surgical oncology physician
61
Companies
604
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$64,921 (51.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$37,904 (29.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23,970 (18.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$25,323
2023
$12,539
2022
$20,738
2021
$24,231
2020
$8,679
2019
$25,712
2018
$9,574
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Stryker Corporation
$37,121
Kerecis Limited
$24,030
Integra LifeSciences Corporation
$11,817
Biom'Up SA
$9,662
Medical Device Business Services, Inc.
$9,644
Ethicon US, LLC
$5,453
AngioDynamics, Inc.
$4,985
Intuitive Surgical, Inc.
$3,624
TRIAD LIFE SCIENCES INC.
$3,600
BAXTER HEALTHCARE
$2,310
Musculoskeletal Transplant Foundation Inc.
$2,025
AbbVie Inc.
$1,859
ACELL, INC.
$1,661
Takeda Pharmaceuticals U.S.A., Inc.
$1,161
Medtronic, Inc.
$1,119
TELA Bio, Inc.
$885
Covidien LP
$830
Baxter Healthcare
$812
Endogastric Solutions, Inc
$463
Lexington Medical, Inc.
$349
Sirtex Medical Inc
$328
Biom'Up France SAS
$285
Analogic Corporation
$266
Smith+Nephew, Inc.
$232
DePuy Synthes Sales Inc.
$186
ABBVIE INC.
$174
BK Medical Holding Company Inc.
$166
Hologic Sales and Service, LLC
$162
Enterra Medical, Inc.
$137
Bolder Surgical LLC
$119
Aroa Biosurgery Incorporated
$111
W. L. Gore & Associates, Inc.
$107
Apollo Endosurgery US Inc
$106
Imbed Biosciences Inc.
$100
KCI USA, Inc
$99
Allergan Inc.
$87
Access Pro Medical, LLC
$81
Shire North American Group Inc
$56
PolyNovo North America LLC
$49
Aesculap, Inc.
$41
Endo Pharmaceuticals Inc.
$38
Allergan, Inc.
$33
Teleflex LLC
$30
LifeNet Health
$28
Davol Inc.
$27
Avanos Medical
$27
Tactile Systems Technology Inc
$25
Alexion Pharmaceuticals, Inc.
$25
Levita Magnetics International Corp.
$25
Alcresta Therapeutics, Inc.
$24
Argentum Medical
$23
Novartis Pharmaceuticals Corporation
$23
Cumberland Pharmaceuticals, Inc.
$23
ATRICURE, INC.
$22
Medtronic USA, Inc.
$21
AtriCure, Inc.
$20
Nestle HealthCare Nutrition Inc.
$19
Bard Access Systems, Inc.
$17
JustRight Surgical LLC
$16
Invuity, Inc.
$14
NESTLE HEALTHCARE NUTRITION INC.
$13
Top 3 companies account for 57.5% of total payments
Associated products mentioned in payments ›
1588 HD 3 CHIP CAMERA · 1688 · 1788 · ADVANCED WOUND CARE · AIM (ADVANCED IMAGING MODALITY) · APPOSE ULC · ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) · Aeon Endostapler · Aeon Endostapler & Echelon Flex Powered Stapler · BioPharma Sol - Non Prod Related · CAIMAN VESSEL SEALERS · CALDOLOR · CERTUS 140 MICROWAVE ABLATION SYSTEM · CODMAN CERTAS · COLLAGENASE SANTYL · CUSTOM IMPLANTS · CYTAL · Caldolor · CoolSeal Generator · Da Vinci Surgical System · ECHELON ENDOPATH · ECHELON ENDOPATH Stapler · ECHELON FLEX Stapler · EEA · EIKON LT ADAPT · EMPRINT · ENSEAL Product Family · ESOPHYX · ETHICON · EVICEL · EVICEL Fibrin Sealant (Human) · Echelon Endopath Staple Line Reinforcement · Echelon Flex · Echelon Powered Circular · Echelon; Endopath · EleVision · Emprint · Enseal · Enseal X1 · Enseal X1 5mm · FLOSEAL · Flexitouch Plus · GATTEX · GORE ENFORM Biomaterial · GORE ENFORM Preperitoneal Biomaterial · GRAFIX · GRAFIX PL · HEMOBLAST · HEMOBLAST BELLOWS · Harmonic · HemoBlast Bellows · Hemoblast · INNOVAMATRIX AC · INTEGRA MESHED BILAYER WOUND MATRIX · INTEGRA WOUND MATRIX (THIN) · IRIS · Integra · JustRight Sealer · JustRight Sealer and CoolSeal Sealer · Kerecis Omega3 SurgiClose · LAPAROSCOPIC INSTRUMENTS · LINX REFLUX MANAGEMENT SYSTEM · LINX Reflux Management System · LigaSure · MEKINIST · MONOCRYL · Magnetic Surgical System · MatriDerm · Matriderm · NANOKNIFE · NASCOBAL · NATRELLE SALINE-FILLED BREAST IMPLANTS · NEUWAVE Flex Microwave Ablation System · NOVOSORB BTM · NanoKnife · Neuwave · No Related Product · OMNIGRAFT · ON-Q* PUMP AND ACCESSORIES · OSTEOCOOL RF ABLATION · OrVil · Overstitch · OviTex 2S · OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) · Ovitex · PERI-STRIPS DRY · PICO Single Use Negative Pressure Wound Therapy · PINPOINT · PROGEL · Phasix Mesh · Photonblade · RELIZORB · SECURESTRAP · SIGNIA · SIR-Spheres Microspheres · SPY TECHNOLOGY · SPY-PHI SYSTEM · STRATAFIX · STRATTICE · STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS · STRAVIX · SURGICEL Family of Absorbable Hemostats · SURGICEL NU-KNIT · SURGIMEND · SYNECOR Biomaterial · Santyl · Situate · Solero · TACHOSIL · TISSEEL · TRIATHLON · TheraGenesis Wound Matrix · Toothed Grasper · Ultomiris · VAC VERAFLO · VISTASEAL · WECK · XCM Biologic Tissue Matrix · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (51%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 2% for surgical oncology physician in TX.
Equivalent to $19,388 per 100 Medicare services performed
Geographic Context
Surgical oncology physicians within 10 mi
5
Per 100K population
0.2
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sharif is a clinical cardiology specialist, with above-average Medicare volume (top 5% in TX), with consulting-driven industry engagement in the top 2% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sharif experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Sharif performed 153 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sharif receive payments from pharmaceutical companies?
Yes. Dr. Sharif received a total of $126,795 from 61 companies across 604 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sharif's costs compare to other surgical oncology physicians in Fort Worth?
Dr. Sharif's average Medicare payment per service is $127. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sharif) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Surgical Oncology Physicians in Fort Worth
Browse surgical oncology physicians in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Surgical Oncology Physicians in TX
Surgical oncology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Surgical Oncology Physicians in TX
Which TX surgical oncology physicians receive the most from drug and device companies.
By company
Stryker Corporation Payments to Doctors
See all physicians who received payments from Stryker Corporation.
By company
Kerecis Limited Payments to Doctors
See all physicians who received payments from Kerecis Limited.
By company
Integra LifeSciences Corporation Payments to Doctors
See all physicians who received payments from Integra LifeSciences Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology